论文部分内容阅读
目的探讨卡维地洛联合缬沙坦治疗慢性心力衰竭的临床效果。方法选取慢性心力衰竭患者100例,按照入组奇偶顺序分组,奇数组为对照组,偶数组为研究组,每组50例。对照组接受缬沙坦治疗,研究组则加用卡维地洛治疗,比较两组临床效果、住院时间、医疗费用,左心射血分数与E/A。结果研究组总有效率高达96.00%高于对照组的74.00%(P<0.05);研究组患者住院时间与医疗费用明显低于对照组(P<0.05);治疗后,但研究组左心射血分数、E/A、高于对照组(P<0.05)。结论慢性心力衰竭患者采取卡维地洛联合缬沙坦治疗能提高临床效果,改善心功能,缩短住院时间,减少医疗费用。
Objective To investigate the clinical effect of carvedilol combined with valsartan in the treatment of chronic heart failure. Methods A total of 100 patients with chronic heart failure were enrolled in this study. They were grouped according to the order of their parity. Odd-numbered groups were control group, and even-numbered groups were study group, 50 cases in each group. The control group received valsartan treatment, while the study group was treated with carvedilol. The clinical effects, hospitalization time, medical expenses, left ventricular ejection fraction and E / A of the two groups were compared. Results The total effective rate was 96.00% in the study group and 74.00% in the control group (P <0.05). The hospitalization time and medical expenses in the study group were significantly lower than those in the control group (P <0.05) Blood fraction, E / A, higher than the control group (P <0.05). Conclusion The treatment of carvedilol combined with valsartan in patients with chronic heart failure can improve the clinical effect, improve the cardiac function, shorten the hospital stay and reduce the medical expenses.